Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, announced today it has raised $4 million in a Series A financing round. The round was led by Dynamk Capital and is expected to close with participation from additional investors by mid-July.

NIH Director Dr. Francis Collins posts a blog featuring the early work by CEO Nicholas (Nick) Reder MD MPH, then medical resident in the pathology department at the University of Washington, and Dr. Jonathan Liu of the mechanical engineering department that was inspired by a technical challenge.